Groundbreaking Bowel Cancer Trial Had Zero Relapses for Patients After 33 Months
A small but substantial tweak to the treatment regime of bowel cancer demonstrated remarkable improvements in survival almost 3 years after surgery. Changing the kind of drug and the delivery window showed substantial improvements over the previous pai…


